Comprehensive Mutation Analysis ofPMS2in a Large Cohort of Probands Suspected of Lynch Syndrome or Constitutional Mismatch Repair Deficiency Syndrome
- 20 July 2016
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 37 (11) , 1162-1179
Abstract
Monoallelic PMS2 germline mutations cause 5%–15% of Lynch syndrome, a midlife cancer predisposition, whereas biallelic PMS2 mutations cause approximately 60% of constitutional mismatch repair deficiency (CMMRD), a rare childhood cancer syndrome. Recently improved DNA‐ and RNA‐based strategies are applied to overcome problematic PMS2 mutation analysis due to the presence of pseudogenes and frequent gene conversion events. Here, we determined PMS2 mutation detection yield and mutation spectrum in a nationwide cohort of 396 probands. Furthermore, we studied concordance between tumor IHC/MSI (immunohistochemistry/microsatellite instability) profile and mutation carrier state. Overall, we found 52 different pathogenic PMS2 variants explaining 121 Lynch syndrome and nine CMMRD patients. In vitro mismatch repair assays suggested pathogenicity for three missense variants. Ninety‐one PMS2 mutation carriers (70%) showed isolated loss of PMS2 in their tumors, for 31 (24%) no or inconclusive IHC was available, and eight carriers (6%) showed discordant IHC (presence of PMS2 or loss of both MLH1 and PMS2). Ten cases with isolated PMS2 loss (10%; 10/97) harbored MLH1 mutations. We confirmed that recently improved mutation analysis provides a high yield of PMS2 mutations in patients with isolated loss of PMS2 expression. Application of universal tumor prescreening methods will however miss some PMS2 germline mutation carriers.Keywords
This publication has 55 references indexed in Scilit:
- Absence of PMS2 mutations in colon‐CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expressionClinical Genetics, 2012
- Agenesis of the corpus callosum and gray matter heterotopia in three patients with constitutional mismatch repair deficiency syndromeEuropean Journal of Human Genetics, 2012
- Paediatric intestinal cancer and polyposis due to bi-allelic PMS2 mutations: Case series, review and follow-up guidelinesEuropean Journal of Cancer, 2011
- A novel pathogenic MLH1 missense mutation, c.112A > C, p.Asn38His, in six families with Lynch syndromeHereditary Cancer in Clinical Practice, 2010
- MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancerHereditary Cancer in Clinical Practice, 2010
- Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramificationsClinical Genetics, 2009
- EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndromeGenetics in Medicine, 2009
- The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 MutationsGastroenterology, 2008
- Patients with an unexplained microsatellite instable tumour have a low risk of familial cancerBritish Journal of Cancer, 2007
- Structure and function of the N‐terminal 40 kDa fragment of human PMS2: a monomeric GHL ATPaseThe EMBO Journal, 2001